Density loss in the optic nerve head capillary could lead to a faster rate of visual field progression as well as an increased risk of developing event progression. Glaucoma is best managed through ...

About The Study: In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ischemic ...

Cavernous malformations of the optic pathway are rare vascular anomalies defined by clusters of dilated, thin‐walled capillaries that may develop along the optic nerve, chiasm, or tract. These lesions ...

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute. The findings suggest a way forward ...

Patients with type 2 diabetes (T2D) on semaglutide or tirzepatide showed a higher incidence of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders compared to other ...